A Pharmaceutical Company That Rose Through Diversification While Others Focused on a Single Field 류성 2025.09.02 오후 08:00 Biotech stocks tumble on rights offerings[K-bio Pulse] 석지헌 2025.08.20 오전 09:00 Jeil Pharma Surge on Orphan Drug Designation[K-Bio Pulse] 석지헌 2025.03.19 오전 08:44 'Drug Technology Transfer' Bridge Bio·HLB Therapeutics Stocks Surge[K-Bio Pulse] 신민준 2025.03.28 오전 07:40 The Achilles’ Heel of Korea’s Biopharma Giants[Yoo Sung’s Pharma National Wealth Theory] 류성 2025.05.15 오전 06:24 Huons Nizoral for Seborrheic Dermatitis in Unpredictable Summer Weather 신민준 2025.07.31 오전 08:46 Huons N makes Japanese debut, launching vitamins on Qoo10 신민준 2025.06.12 오전 11:36 HLB’s NDA Rejected Again; Resubmission in May, FDA Decision by July 김새미 2025.03.23 오후 05:16 Prestige Biologics Order Backlog Tops KRW 30 Billion, Marking Growth Milestone 송영두 2025.03.25 오전 07:52 Clinomics Faces Investor Caution, T&R Biofab Rises Despite Regulatory Setback[K-bio Pulse] 김승권 2025.03.20 오전 08:03 더 보기 로딩중..
Single-focus
Single-focus
![Biotech stocks tumble on rights offerings[K-bio Pulse]](https://image.edaily.co.kr/images/photo/files/NP/S/2025/08/PS25082000378b.jpg)
![Jeil Pharma Surge on Orphan Drug Designation[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25031900311b.jpg)
!['Drug Technology Transfer' Bridge Bio·HLB Therapeutics Stocks Surge[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25032800273b.jpg)
![The Achilles’ Heel of Korea’s Biopharma Giants[Yoo Sung’s Pharma National Wealth Theory]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/05/PS25051500174b.jpg)
![Clinomics Faces Investor Caution, T&R Biofab Rises Despite Regulatory Setback[K-bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/03/PS25032000272b.jpg)